ActVI-ORFA directs metabolic flux towards actinorhodin by preventing intermediate degradation is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NM-INBRE
Grant: P20 GM103451
Academy of Finland
Grant: 354998
Development of antracycline anticancer agents by metabolic engineering
National Institutes of Health
Grant: 3P20GM103451-21S1
Deep sequencing SARS-CoV-2 samples from New Mexico to interrogate immunological selection on genetic variants
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
MeSH Terms
Keywords